← Back to Patent Explorer
US4056673A Expired / Lapsed US ⏱️ 0.0 years remaining

Phosphonoacetic acid derivatives of nucleosides

Assignee: Hoffmann La Roche Inc
•
Filing: 1976-07-16
•
Granted: 1977-11-01
•
Expires: 1996-07-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Phosphonoacetic acid derivatives of purine and pyrimidine nucleosides are novel antiviral and/or antineoplastic agents.

Inventors

  • 👤 Edgar Philip Heimer
  • 👤 Alexander Leopold Nussbaum

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 11:37
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/06; C07H19/10; C07H19/16; C07H19/20

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 64 words
A compound of the formula ##STR13## wherein B is selected from (a) the group of nucleobases consisting of adenine, guanine, cytidine, thymidine and uracil or (b) a 5-halopyrimidine; X is hydrogen, hydroxy, or ##STR14## Y is hydrogen or ##STR15## and Z is ##STR16## or, when either of X and Y is other than hydrogen or hydroxy, is hydrogen: and pharmaceutically acceptable base salts thereof.
Claim 2
Dependent Claim 64 words
A compound of the formula ##STR13## wherein B is selected from (a) the group of nucleobases consisting of adenine, guanine, cytidine, thymidine and uracil or (b) a 5-halopyrimidine; X is hydrogen, hydroxy, or ##STR14## Y is hydrogen or ##STR15## and Z is ##STR16## or, when either of X and Y is other than hydrogen or hydroxy, is hydrogen: and pharmaceutically acceptable base salts thereof.
Claim 3
Dependent Claim 18 words
The compound of claim 1 wherein B is a nucleobase consisting of adenine, guanine, cytidine, thymidine and uracil.
Claim 4
Dependent Claim 8 words
The compound of claim 2 which is adenosine-5'-mono-carboxymethylphosphonate.
Claim 5
Dependent Claim 8 words
The compound of claim 2 which is 2'-deoxyadenosine-5'-mono-carboxymethylphosphonate.
Claim 6
Dependent Claim 8 words
The compound of claim 2 which is guanosine-5'-mono-carboxymethylphosphonate.
Claim 7
Dependent Claim 8 words
The compound of claim 2 which is adenosine-2'(3')-5'-bis-(carboxymethylphosphonate).
Claim 8
Dependent Claim 8 words
The compound of claim 2 which is arabinoadenosine-5'-mono-carboxymethylphosphonate.
Claim 9
Dependent Claim 8 words
The compound of claim 2 which is thymidine-5'-mono-carboxymethylphosphonate.
Claim 10
Dependent Claim 8 words
The compound of claim 2 which is uridine-5'-mono-carboxymethylphosphonate.
Claim 11
Dependent Claim 10 words
The compound of claim 1 wherein B is a 5'-halopyrimidine.
Claim 12
Dependent Claim 8 words
The compound of claim 10 which is 5-fluoro-2'-deoxyuridine-5'-mono-carboxymethylphosphonate.
Claim 13
Dependent Claim 8 words
The compound of claim 10 which is 5-ioso-2'-deoxyuridine-5'-mono-carboxymethylphosphonate.
Claim 14
Dependent Claim 8 words
The compound of claim 10 which is 5-bromo-2'-deoxyuridine-5'-mono-carboxymethylphosphonate.

References Cited (Backward Citations)

US3238191A Cited
US3201389A Cited
US3433783A Cited
US3560478A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-10-31 1981-05-02 1981-11-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-10-31 1985-05-02 1985-11-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-10-31 1989-05-02 1989-11-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag